`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`MYLAN PHARMACEUTICALSINC.,
`Petitioner,
`
`V.
`
`SANOFI-AVENTIS DEUTSCHLAND GMBH,
`Patent Owner
`
`
`
`IPR2018-01670
`Case No.
`Case No
`. IPR2018-01675
`Case No.
`IPR2018-01676
`IPR2018-01678
`Case No.
`Case No.
`IPR2018-01679
`Case No.
`IPR2018-01680
`IPR2018-01682
`Case No.
`Case No.
`IPR2018-01684
`Case No.
`IPR2019-00122
`U.S. Patent No. 8,603,044
`U.S. Patent No. 8,679,069
`U.S. Patent No. 8,992,486
`US. Patent No. 9,526,844
`U.S. Patent No. 9,604,008
`
`
`DECLARATION OF ROBERT VEASEY
`
`Sanofi Exhibit 2319.001
`Mylan v. Sanofi
`IPR2018-01675
`
`Sanofi Exhibit 2319.001
`Mylan v. Sanofi
`IPR2018-01675
`
`
`
`I, Robert Veasey, declare as follows:
`
`1.
`
`I am a Senior Medical and Scientific Sector Manager for DCA Design
`
`International Ltd (“DCA”).
`
`2.
`
`Ihave reviewed Exhibits 2167, 2168, and 2211. Each of these
`
`exhibits are true and correct copies of animations that were created at DCA. I have
`
`personal knowledge of these animations as they were created at my direction.
`
`3.
`
`Exhibit 2167 is an animation of Giambattista (U.S. Patent No.
`
`6,932,794) modified based on Klitgaard (U.S. Patent No. 6,582,404). This
`
`animation was created using SolidWorks and Adobe Premier. As can be seen in
`
`the animationitself, the 3D models of the Giambattista and Klitgaard components
`
`were created from the figures contained in the Giambattista and Klitgaard patents.
`
`4,
`
`Exhibit 2168 is an animation of an alternative embodiment of
`
`Giambattista modified based on Klitgaard. This animation was created using
`
`SolidWorks, Blender and Adobe Premier. As can be seen in the animationitself,
`
`the 3D models of the Giambattista and Klitgaard components were created from
`
`the figures contained in the Giambattista and Klitgaard patents.
`
`5.
`
`Exhibit 2211 is an animation explaining the Collar Friction
`
`Demonstrator Model. This animation was created using SolidWorks and Adobe
`
`Premier. As can be seen in the animationitself, the 3D models of components
`
`Sanofi Exhibit 2319.002
`Mylan v. Sanofi
`IPR2018-01675
`
`Sanofi Exhibit 2319.002
`Mylan v. Sanofi
`IPR2018-01675
`
`
`
`from Steenfeldt-Jensen (U.S. Patent No. 6,235,004) were created from the figures
`
`contained in Steenfeldt-Jensen.
`
`6.
`
`I have reviewed a document labeled Exhibit 2121. This exhibit is a
`
`true and correct copy of a document created at DCA entitled, DBA Design
`
`Effectiveness Awards 2009: SoloStar® A disposable pen injectorfor insulin. I was
`
`the primary author of this document.
`
`7.
`
`I declare that all statements made herein of my own knowledge are
`
`true and that all statements made on information and belief are believed to be true;
`
`and further that these statements were made with the knowledge that willful false
`
`statements and the like so made are punishable by fine or imprisonment, or both,
`
`under Section 1001 of Title 18 of the United States code.
`
`
`
`
`
`Dated:1SJuly 2019 _EVeosen|By:
`
`.
`
`Robert Veasey
`
`‘
`
`3
`
`Sanofi Exhibit 2319.003
`Mylan v. Sanofi
`IPR2018-01675
`
`Sanofi Exhibit 2319.003
`Mylan v. Sanofi
`IPR2018-01675
`
`